Prestige Consumer Healthcare Inc. (PBH)
USD 78.79
(-1.99%)
USD 78.79
(-1.99%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 282.01 Million USD | 1.63% |
| 2023 | 277.49 Million USD | -4.55% |
| 2022 | 290.72 Million USD | 16.26% |
| 2021 | 250.07 Million USD | -4.21% |
| 2020 | 261.06 Million USD | 0.45% |
| 2019 | 259.89 Million USD | -27.93% |
| 2018 | 360.63 Million USD | 48.5% |
| 2017 | 242.85 Million USD | 17.38% |
| 2016 | 206.89 Million USD | 4.14% |
| 2015 | 198.66 Million USD | 31.19% |
| 2014 | 151.43 Million USD | -2.51% |
| 2013 | 155.33 Million USD | 24.7% |
| 2012 | 124.56 Million USD | 31.49% |
| 2011 | 94.73 Million USD | 24.68% |
| 2010 | 75.98 Million USD | -6.43% |
| 2009 | 81.2 Million USD | 5.34% |
| 2008 | 77.09 Million USD | 8.88% |
| 2007 | 70.8 Million USD | -3.45% |
| 2006 | 73.33 Million USD | 7.21% |
| 2005 | 68.4 Million USD | 96.33% |
| 2004 | 34.84 Million USD | 100.82% |
| 2003 | 17.34 Million USD | 38.04% |
| 2002 | 12.56 Million USD | 1672.64% |
| 2001 | 709 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 71.1 Million USD | -0.93% |
| 2024 Q4 | 63.98 Million USD | -10.02% |
| 2024 FY | 259.46 Million USD | -6.5% |
| 2024 Q1 | 69.47 Million USD | 7.65% |
| 2024 Q2 | 71.77 Million USD | 3.3% |
| 2023 Q2 | 76.62 Million USD | 4.81% |
| 2023 FY | 277.49 Million USD | -4.55% |
| 2023 Q4 | 64.54 Million USD | 2.1% |
| 2023 Q3 | 63.21 Million USD | -17.5% |
| 2023 Q1 | 73.1 Million USD | 2.33% |
| 2022 Q3 | 72.46 Million USD | -8.45% |
| 2022 FY | 290.72 Million USD | 16.26% |
| 2022 Q1 | 67.67 Million USD | 2.35% |
| 2022 Q2 | 79.15 Million USD | 16.97% |
| 2022 Q4 | 71.43 Million USD | -1.42% |
| 2021 Q2 | 64.75 Million USD | 20.48% |
| 2021 Q3 | 65.44 Million USD | 1.06% |
| 2021 Q1 | 53.74 Million USD | -23.21% |
| 2021 FY | 250.07 Million USD | -4.21% |
| 2021 Q4 | 66.11 Million USD | 1.03% |
| 2020 Q2 | 67.4 Million USD | 7.71% |
| 2020 Q4 | 69.99 Million USD | 14.57% |
| 2020 FY | 261.06 Million USD | 0.45% |
| 2020 Q1 | 62.58 Million USD | 0.56% |
| 2020 Q3 | 61.09 Million USD | -9.36% |
| 2019 Q4 | 62.23 Million USD | 0.88% |
| 2019 Q3 | 61.69 Million USD | -9.05% |
| 2019 Q2 | 67.83 Million USD | -0.45% |
| 2019 Q1 | 68.13 Million USD | -58.47% |
| 2019 FY | 259.89 Million USD | -27.93% |
| 2018 Q4 | 164.08 Million USD | 155.69% |
| 2018 FY | 360.63 Million USD | 48.5% |
| 2018 Q1 | 64.44 Million USD | -16.15% |
| 2018 Q2 | 67.94 Million USD | 5.42% |
| 2018 Q3 | 64.17 Million USD | -5.55% |
| 2017 Q4 | 76.86 Million USD | 31.02% |
| 2017 FY | 242.85 Million USD | 17.38% |
| 2017 Q3 | 58.66 Million USD | 10.88% |
| 2017 Q2 | 52.9 Million USD | -51.63% |
| 2017 Q1 | 109.37 Million USD | 106.44% |
| 2016 Q2 | 50.04 Million USD | 0.63% |
| 2016 Q4 | 52.98 Million USD | -2.14% |
| 2016 Q3 | 54.14 Million USD | 8.19% |
| 2016 FY | 206.89 Million USD | 4.14% |
| 2016 Q1 | 49.73 Million USD | 1.86% |
| 2015 FY | 198.66 Million USD | 31.19% |
| 2015 Q3 | 54.75 Million USD | -2.27% |
| 2015 Q1 | 39.06 Million USD | 11.34% |
| 2015 Q2 | 56.02 Million USD | 43.42% |
| 2015 Q4 | 48.82 Million USD | -10.83% |
| 2014 Q2 | 40.95 Million USD | 20.31% |
| 2014 Q4 | 35.08 Million USD | -15.15% |
| 2014 Q3 | 41.35 Million USD | 0.96% |
| 2014 FY | 151.43 Million USD | -2.51% |
| 2014 Q1 | 34.04 Million USD | -10.17% |
| 2013 Q3 | 38.27 Million USD | -2.83% |
| 2013 FY | 155.33 Million USD | 24.7% |
| 2013 Q4 | 37.89 Million USD | -0.99% |
| 2013 Q2 | 39.38 Million USD | -0.96% |
| 2013 Q1 | 39.77 Million USD | -13.41% |
| 2012 Q4 | 45.93 Million USD | 45.85% |
| 2012 Q1 | 22.63 Million USD | -18.24% |
| 2012 Q2 | 24.5 Million USD | 8.27% |
| 2012 FY | 124.56 Million USD | 31.49% |
| 2012 Q3 | 31.49 Million USD | 28.52% |
| 2011 Q2 | 18.75 Million USD | 6.81% |
| 2011 Q1 | 17.55 Million USD | 0.52% |
| 2011 Q4 | 27.68 Million USD | -10.67% |
| 2011 Q3 | 30.98 Million USD | 65.23% |
| 2011 FY | 94.73 Million USD | 24.68% |
| 2010 Q2 | 23.1 Million USD | 16.74% |
| 2010 Q4 | 17.46 Million USD | 8.46% |
| 2010 FY | 75.98 Million USD | -6.43% |
| 2010 Q1 | 19.79 Million USD | 32.82% |
| 2010 Q3 | 16.1 Million USD | -30.29% |
| 2009 Q2 | 25.75 Million USD | 42.72% |
| 2009 Q3 | 22.49 Million USD | -12.65% |
| 2009 FY | 81.2 Million USD | 5.34% |
| 2009 Q4 | 14.9 Million USD | -33.77% |
| 2009 Q1 | 18.04 Million USD | 9.92% |
| 2008 Q4 | 16.41 Million USD | -11.41% |
| 2008 Q2 | 23.95 Million USD | 31.75% |
| 2008 Q3 | 18.53 Million USD | -22.64% |
| 2008 Q1 | 18.18 Million USD | 9.5% |
| 2008 FY | 77.09 Million USD | 8.88% |
| 2007 Q1 | 16.24 Million USD | -31.55% |
| 2007 Q2 | 19.12 Million USD | 17.71% |
| 2007 Q3 | 18.82 Million USD | -1.58% |
| 2007 Q4 | 16.6 Million USD | -11.78% |
| 2007 FY | 70.8 Million USD | -3.45% |
| 2006 Q1 | 18.25 Million USD | 23.36% |
| 2006 Q4 | 23.74 Million USD | 44.95% |
| 2006 Q2 | 16.96 Million USD | -7.05% |
| 2006 Q3 | 16.37 Million USD | -3.48% |
| 2006 FY | 73.33 Million USD | 7.21% |
| 2005 Q1 | -20.98 Million USD | 0.0% |
| 2005 Q2 | -17.06 Million USD | 18.69% |
| 2005 FY | 68.4 Million USD | 96.33% |
| 2005 Q3 | 15.56 Million USD | 191.21% |
| 2005 Q4 | 14.79 Million USD | -4.89% |
| 2004 FY | 34.84 Million USD | 100.82% |
| 2003 FY | 17.34 Million USD | 38.04% |
| 2002 FY | 12.56 Million USD | 1672.64% |
| 2001 FY | 709 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cardinal Health, Inc. | 5 Billion USD | 94.36% |
| Cencora | 7.73 Billion USD | 96.354% |
| McKesson Corporation | 8.27 Billion USD | 96.592% |
| Owens & Minor, Inc. | 2.11 Billion USD | 86.653% |